Sad to see you leave KP your research contribution has been of great value.
I spoke to Mark today, he is very excited about the deal which allows us to now focus on 1102. He acknowledges our concerns re non disclosure and is working towards a solution for shareholders. More coming over the next few weeks so hold tight.... This is a big win for biotech's in Australia as not many companies make it past P2 and even less actually strike a deal....
Sack Diamond, page-45
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
